Searchable abstracts of presentations at key conferences in endocrinology

ea0032p880 | Pituitary – Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2013

Limitations of basal IGF-1 status reflecting the severity of growth hormone deficiency and predicting response to replacement therapy

Perez Laura , Parra Paola , Fernandez Alberto , Guillen Maria Augusta , Pallardo Luis Felipe , Alvarez Cristina

Generously supported by IPSEN)-->GH replacement (GHR) in adults has demonstrated to improve body composition, inflammatory cardiovascular biomarkers and quality of life. However, this benefit is uneven, and factors that stratify treatment response are required.According to current guidelines, low IGF-I levels in specific conditions provide strong evidence for GH deficiency (GHD). Nevertheless, normal levels do ...

ea0059p142 | Neuroendocrinology and pituitary | SFEBES2018

A single-centre audit of treatment outcomes in 185 acromegaly patients under regular follow-up

Muhammad Shoaib Khan Sardar , Mola Laura , Perez-Fernandez Leticia , Vincent Alex , Grossman Ashley , Cudlip Simon , Jafar-Mohammadi Bahram , Pal Aparna

Transsphenoidal adenomectomy (TSA) is the recommended primary therapy in most patients with acromegaly and results in remission for majority of microadenomas and a proportion of macroadenomas depending on extent of surgically accessible disease. Acromegaly is associated with significant mortality and morbidity, hence a combination of treatment modalities may be needed to achieve disease control.Methods: A retrospective casenotes review was conducted and ...

ea0049gp235 | Thyroid Cancer | ECE2017

Clinical Utility of response to therapy in combination with BRAF in risk assessment of thyroid cancer

Fernandez Laura Perez , De la Vieja Escolar Antonio , Zafon Carles , Galofre Juan Carlos , Riesco-Eizaguirre Garcilaso , Spanish Task Force for the study of BRAF SEEN Garcilaso

Response to therapy re-stratification approach has been recently included in the 2015 ATA guidelines as a risk-adapted approach to management of thyroid cancer. Our aim was to investigate the clinical utility of response to therapy variables obtained during early follow-up in combination with BRAF, a prominent oncogene in thyroid cancer with prognostic value. This was a retrospective multicenter study of 871 patients at 11 centers in Spain with papillary thyroid cancer followe...

ea0090ep1081 | Late Breaking | ECE2023

Cushing Syndrome Due To Acth-Secreting Pheochromocytoma: A Case Report

Ruiz Arnal Laura , Perez Garcia Leire , Agea Diaz Leire , Vega Blanco Maria , Rosario Fuentes Gomez Clara , Gonzalez Gonzalez Sheila , Galarza Montes Aitor , Perez Alonso Octavio , Garaizabal Azkue Leire , Gonzalez Fernandez Mikel

Introduction: The most frequent causes of ACTH-dependent Cushing’s syndrome are of pituitary origin and, less frequently, due to ectopic secretion of bronchial carcinoid, small cell lung cancer, and neuroendocrine tumors; it is rarely caused by an ACTH-producing pheochromocytoma.Methodology: We present a case of a 44-year-old female with a history of poorly controlled type 2 diabetes, hypertension, and long-standing obesity with no genetic predispos...